Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001899
Filing Date
2022-01-13
Accepted
2022-01-13 16:20:37
Documents
2
Period of Report
2022-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1580
2 EX-24 DOCUMENT attachment1.htm EX-24 4546
  Complete submission text file 0000899243-22-001899.txt   7746
Mailing Address 10990 WILSHIRE BLVD, SUITE 1200 LOS ANGELES CA 90024
Business Address
MOLINA ARTURO MD (Reporting) CIK: 0001398940 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39333 | Film No.: 22529268

Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Issuer) CIK: 0001538927 (see all company filings)

EIN.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)